CIK 0000907654
- Non-accelerated filer
- Smaller reporting company
Oruka Therapeutics, Inc.
Sign in to watch- Ticker
- ORKA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 363855489
- Phone
- +1 650-606-7910
- Business address
- 855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
- Former names
- ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $20,577,126
- in 17 filings, $20.2M under 10b5-1 plans
Net −$20,577,126. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Klein Lawrence Otto −$11.6M Chief Executive Officer sold 12% of stake
- Agarwal Arjun −$2.8M Senior Vice President, Finance sold 68% of stake
- Goncalves Joana −$2.0M Chief Medical Officer sold 41% of stake
- BALL KRISTINE M −$1.9M Director sold 100% of stake
- Quinlan Paul T −$1.7M General Counsel sold 40% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-06-09 | Ozeroff Christopher David S.V.P., General Counsel | Grant or award · Stock Option (right to buy) | +30,200 | 30,200 | ||
| 2016-06-09 | Selby Brian L. VP, Finance | Grant or award · Stock Option (right to buy) | +15,800 | 15,800 | ||
| 2016-06-09 | Selby Brian L. VP, Finance | Grant or award · Stock Option (right to buy) | +32,100 | 32,100 | ||
| 2016-04-05 | BRISTOW MICHAEL R See Remarks | Sale | −724 | $3.52 | $3K | 44,610 |
| 2016-04-05 | Keuer Thomas A Chief Operating Officer | Sale | −384 | $3.52 | $1K | 16,097 |
| 2016-04-05 | Ozeroff Christopher David S.V.P., General Counsel | Sale | −366 | $3.52 | $1K | 19,585 |
| 2016-04-04 | Selby Brian L. VP, Finance | Sale | −1,114 | $3.52 | $4K | 3,026 |
| 2016-03-01 | Keuer Thomas A Chief Operating Officer | Sale | −457 | $3.53 | $2K | 16,481 |
| 2016-03-01 | Ozeroff Christopher David S.V.P., General Counsel | Sale | −458 | $3.51 | $2K | 19,951 |
| 2016-03-01 | BRISTOW MICHAEL R See Remarks | Sale | −752 | $3.50 | $3K | 45,334 |
| 2016-02-29 | Selby Brian L. VP, Finance | Sale | −160 | $3.46 | $554 | 4,140 |
| 2016-02-11 | Grais Linda S Director | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2016-02-11 | Woosley Raymond L. Director | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2016-02-11 | MITCHELL DANIEL J Director | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2016-02-11 | CONWAY ROBERT E Director | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2015-10-16 | Keuer Thomas A Chief Operating Officer | Sale | −496 | $5.14 | $3K | 16,938 |
| 2015-09-18 | BRISTOW MICHAEL R See Remarks | Sale | −1,809 | $6.33 | $11K | 46,086 |
| 2015-09-18 | Selby Brian L. VP, Finance | Sale | −476 | $6.23 | $3K | 4,300 |
| 2015-09-18 | Ozeroff Christopher David S.V.P., General Counsel | Sale | −1,129 | $6.32 | $7K | 20,409 |
| 2015-09-18 | Keuer Thomas A Chief Operating Officer | Sale | −680 | $6.33 | $4K | 17,407 |
Page 23 of 24 · 473 trades